The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum
Abstract
PURPOSE: The purpose of this study was to evaluate the clinical efficacy of positron emission tomography with 2-[18F] fluoro-2-deoxy-D-glucose compared with computed tomography plus other conventional diagnostic studies in patients suspected of having metastatic or recurrent colorectal adenocarcinoma. METHODS: The records of 105 patients who underwent 101 computed tomography and 109 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography scans for suspected metastatic or recurrent colorectal adenocarcinoma were reviewed. Clinical correlation was confirmed at time of operation, histopathologically, or by clinical course. RESULTS: The overall sensitivity and specificity of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in detection of clinically relevant tumor were higher (87 and 68 percent) than for computed tomography plus other conventional diagnostic studies (66 and 59 percent). The sensitivity of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in detecting mucinous cancer was lower (58 percent; n = 16) than for nonmucinous cancer (92 percent; n = 93). The sensitivity of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in detecting locoregional recurrence (n = 70) was higher than for computed tomography plus colonoscopy (90 vs. 71 percent, respectively). The sensitivity of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in detecting hepatic metastasis (n = 101) was higher than for computed tomography (89 vs. 71 percent). The sensitivity of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in detecting extrahepatic metastases exclusive of locoregional recurrence (n = 101) was higher than for computed tomography plus other conventional diagnostic studies (94 vs. 67 percent). 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography altered clinical management in a beneficial manner in 26 percent of cases (26/101) when compared with evaluation by computed tomography plus other conventional diagnostic studies. CONCLUSION: 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography is more sensitive than computed tomography for the detection of metastatic or recurrent colorectal cancer and may improve clinical management in one-quarter of cases. However, 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography is not as sensitive in detecting mucinous adenocarcinoma, possibly because of the relative hypocellularity of these tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parker, S. L., Tong, T., Bolden, S., & Wingo, P. A. (1997) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.47.1.5 · Cited by 2,003
Resection of colorectal liver metastases
Scheele, J., Stang, R., Altendorf‐Hofmann, A., & Paul, M. (1995) · World Journal of Surgery · doi:10.1007/bf00316981 · Cited by 1,539
Abdel-Nabi, H., Doerr, R. J., Lamonica, D. M., Cronin, V. R., Galantowicz, P. J., Carbone, G. M., & Spaulding, M. B. (1998) · Radiology · doi:10.1148/radiology.206.3.9494497 · Cited by 424
Schoemaker, D., Black, R., Giles, L., & Toouli, J. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70626-2 · Cited by 386
Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma.
Higashi, K., Ueda, Y., Seki, H., Yuasa, K., Oguchi, M., Noguchi, T., Taniguchi, M., Tonami, H., Okimura, T., & Yamamoto, I. (1998) · PubMed · Cited by 351
Follow-Up of Patients with Colorectal Cancer A Meta-Analysis
Bruinvels, D. J., Stiggelbout, A. M., Kievit, J., van Houwellngen, H. C., F. Habbema, J. D., & van de Velde, C. J. H. (1994) · Annals of Surgery · doi:10.1097/00000658-199402000-00009 · Cited by 322
Follow-up after curative surgery for colorectal carcinoma: Randomized comparison with no follow-up
Ohlsson, B., Breland, U., Ekberg, H., Graffner, H., & Tranberg, K.-G. (1995) · Diseases of the Colon & Rectum · doi:10.1007/bf02054122 · Cited by 308
Whole-Body PET Imaging With [18F]Fluorodeoxyglucose in Management of Recurrent Colorectal Cancer
Valk, P. E. (1999) · Archives of Surgery · doi:10.1001/archsurg.134.5.503 · Cited by 291
Ogunbiyi, O. A., Flanagan, F. L., Dehdashti, F., Siegel, B. A., Trask, D. D., Birnbaum, E. H., Fleshman, J. W., Read, T. E., Philpott, G. W., & Kodner, I. J. (1997) · Annals of Surgical Oncology · doi:10.1007/bf02303744 · Cited by 268
Self-citationRecurrence of colorectal tumors: PET evaluation.
Strauss, L. G., Clorius, J. H., Schlag, P., Lehner, B., Kimmig, B., Engenhart, R., Marin-Grez, M., Helus, F., Oberdorfer, F., & Schmidlin, P. (1989) · Radiology · doi:10.1148/radiology.170.2.2783494 · Cited by 268
Cited by
(2001) · PubMed · Cited by 943
Kinkel, K., Lu, Y., Both, M., Warren, R. S., & Thoeni, R. F. (2002) · Radiology · doi:10.1148/radiol.2243011362 · Cited by 621
Wiering, B., Krabbe, P. F. M., Jager, G. J., Oyen, W. J. G., & Ruers, T. J. M. (2005) · Cancer · doi:10.1002/cncr.21569 · Cited by 256
PET and PET-CT for evaluation of colorectal carcinoma
Delbeke, D., & Martin, W. H. (2004) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2004.03.006 · Cited by 110
Metadata
- Authors
- Whiteford, M. H., Whiteford, H. M., Yee, L. F., Ogunbiyi, O. A., Dehdashti, F., Siegel, B. A., Birnbaum, E. H., Fleshman, J. W., Kodner, I. J., & Read, T. E.
- Venue
- Diseases of the Colon & Rectum
- Published
- 2000-06
- Volume
- 43
- Issue
- 6
- Pages
- 759-767
- ISSN
- 0012-3706 (ISSN-L)
- OpenAlex
- W2013701971
- Cited by
- 298
- References
- 22
- FWCI
- 15.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. https://app.cochat.ai/papers/10.1007/bf02238010
- The paper
- Whiteford, M. H., Whiteford, H. M., Yee, L. F., Ogunbiyi, O. A., Dehdashti, F., Siegel, B. A., Birnbaum, E. H., Fleshman, J. W., Kodner, I. J., & Read, T. E. (2000). Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Diseases of the Colon & Rectum. https://doi.org/10.1007/bf02238010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.